Collateral for a security interest recorded May 4, 2024 (Biopharma Credit PLC).
Term ends Aug 16, 2037 · High confidence
Held by Novocure GmbH
Filed Nov 27, 2019 as application 29/715,151 · Granted Aug 16, 2022
Base term, 15 years from grant
Today
2022
2037
Clock starts
Aug 16, 2022
Aug 16, 2022
Term ends
Aug 16, 2037
Aug 16, 2037
base term
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
15 years from grant
Base term
No maintenance fees are payable on this kind of patent.
4
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term is its base term, 15 years from grant, with no adjustment for prosecution delay. No maintenance fees are payable on this kind of patent. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 15 years from grant | Granted Aug 16, 2022 | Aug 16, 2037 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Computed term end | The steps above, in order | Aug 16, 2037 | High confidence |
This family
| US D961,091 | this patent Aug 2037 | Aug 2037 |
| US D1,010,138 | In force Jan 2039 | Jan 2039 |
| US D1,010,139 | In force Jan 2039 | Jan 2039 |
| US D1,056,216 | In force Dec 2039 | Dec 2039 |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jul 31, 2020 Reel 53364, frame 964 | Kirson, Eilon; Wasserman, Yoram; Halavee, Noa | Novocure GmbH | Assignment of Assignor's Interest |
| Nov 6, 2020 Reel 54344, frame 510 | Novocure GmbH | JPMorgan Chase Bank, N.A., as Administrative Agent | Security Interest |
| Apr 24, 2024 Reel 67211, frame 839 | JPMorgan Chase Bank, N.A., as Administrative Agent | Novocure GmbH | Release of Security Interest |
| May 4, 2024 Reel 67315, frame 399 | Novocure GmbH (Switzerland) | Biopharma Credit PLC | Patent Security Agreement |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center
No maintenance fees are payable on this kind of patent, so the record carries no fee events.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Aug 2037
Term ends Aug 16, 2037. No maintenance fees are payable on this kind of patent
Citations
8
later US patents cite this one
That is above the median of design patents granted in 2022 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.